What are the indications for intravenous albumin?

IV Albumin Indications

Based on the most recent and highest-quality evidence, IV albumin has only TWO evidence-supported indications: (1) patients with cirrhosis undergoing large-volume paracentesis (>5L) and (2) patients with cirrhosis and spontaneous bacterial peritonitis. 1

Evidence-Based Indications (Supported by Guidelines)

Strong Indications in Cirrhosis

The 2024 International Collaboration for Transfusion Medicine Guidelines (ICTMG) provides the most current evidence-based framework 1:

1. Large-Volume Paracentesis (>5L)

• Conditional recommendation to prevent paracentesis-induced circulatory dysfunction
• Dose: 6-8 g per liter of ascites removed
• Very low certainty of evidence, but consistent across multiple guidelines 1

2. Spontaneous Bacterial Peritonitis (SBP)

• Conditional recommendation in conjunction with antibiotics
• Dose: 1.5 g/kg at diagnosis, followed by 1 g/kg on day 3
• Reduces risk of hepatorenal syndrome and mortality 1

NOT Recommended Despite Common Use

The ICTMG guidelines explicitly recommend AGAINST albumin use in 12 of 14 clinical scenarios where it is commonly prescribed 1:

Critical Care Settings:

• NOT suggested for first-line volume replacement in critically ill adults (excluding thermal injuries/ARDS) - Conditional recommendation, moderate certainty 1
• NOT suggested to increase serum albumin levels in hypoalbuminemia 1
• NOT suggested for thermal injuries or ARDS volume replacement 1
• NOT suggested with diuretics for extravascular fluid removal 1

Kidney Replacement Therapy:

• NOT suggested for prevention or treatment of intradialytic hypotension 1
• NOT suggested for improving ultrafiltration 1

Pediatric/Neonatal:

• NOT suggested in preterm neonates with respiratory distress 1
• NOT suggested in preterm neonates for volume replacement 1
• NOT suggested in pediatric cardiovascular surgery 1

Cardiovascular Surgery:

• NOT suggested for priming bypass circuits or volume replacement in adults 1

Controversial/Emerging Indications

Hepatorenal Syndrome

• Multiple regional guidelines (European, French, American, Italian) recommend albumin with terlipressin 1
• However, ICTMG refrained from making a recommendation due to lack of clinical trial evidence comparing albumin versus no albumin (prior trials used albumin in both arms) 1
• This represents a divergence between expert opinion and evidence-based guidelines

Sepsis/Septic Shock

• 2021 Surviving Sepsis Campaign suggests albumin when patients require large volumes of crystalloids 1
• French guidelines (2022) state albumin is probably NOT recommended as first-line treatment versus crystalloids to reduce mortality or renal replacement therapy requirement 2
• No mortality benefit demonstrated in large trials 2

Long-Term Albumin in Cirrhosis with Ascites

• Italian guidelines (2020) include albumin for ascites requiring moderate diuretics as outpatient treatment 1
• Emerging evidence suggests potential disease-modifying effects 3
• Not yet widely adopted in other international guidelines

Clinical Algorithm for Decision-Making

Step 1: Identify the Clinical Scenario

• Cirrhosis with large-volume paracentesis (>5L)? → Use albumin
• Cirrhosis with SBP? → Use albumin with antibiotics

Step 2: If NOT Above Scenarios, Default is NO ALBUMIN

• Hypoalbuminemia alone? → Do NOT use albumin 1
• Septic shock requiring crystalloids? → Crystalloids first-line; albumin NOT routinely recommended 2
• Intradialytic hypotension? → Do NOT use albumin 1
• Volume resuscitation in ICU? → Crystalloids first-line 1

Step 3: Document Rationale

• Studies show only 30-50% of albumin prescriptions are for evidence-based indications 4, 5
• Inappropriate use wastes approximately $300,000 annually per institution 5

Critical Pitfalls to Avoid

1. Do NOT use albumin to "correct" low serum albumin levels - Hypoalbuminemia is a marker of illness severity, not a treatment target 1, 6

2. Do NOT assume albumin is superior to crystalloids for volume resuscitation - No mortality benefit demonstrated in general critical care populations 1

3. Do NOT use albumin for nutritional purposes - Completely inappropriate indication 7, 6

4. Beware of capillary leak states - In sepsis and extensive injuries, albumin may leak into interstitial space, potentially worsening outcomes 1, 8

5. Monitor for adverse effects: fluid overload, hypotension, hemodilution requiring transfusion, anaphylaxis, and peripheral gangrene from dilution of natural anticoagulants 1, 8

Dosing When Indicated

Large-Volume Paracentesis:

• 6-8 g per liter of ascites removed (typically 25% albumin solution) 8

Spontaneous Bacterial Peritonitis:

• 1.5 g/kg at diagnosis
• 1 g/kg on day 3 8

Administration:

• Rate should not exceed 2 mL/minute in hypoproteinemic patients to avoid circulatory overload and pulmonary edema 8
• Can be given undiluted or diluted in 0.9% NaCl or 5% dextrose 8

Key Takeaway

The evidence overwhelmingly demonstrates that albumin is overused in clinical practice. Of 14 recommendations in the most recent comprehensive guidelines, only 2 conditionally support albumin use, both in cirrhosis complications 1. The default position should be NO albumin unless the patient has cirrhosis with large-volume paracentesis or SBP.